Data as of Q4 2025 (Dec 31, 2025)
APUS

APIMEDS PHARMACEUTICALS US I

Institutional Ownership · Q4 2025

Filing: Q4 2025

APIMEDS PHARMACEUTICALS US I (APUS) is held by 7 institutional investors with combined holdings of $648,947. Major holders include Hemenway Trust Co LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT,.

💰 Dark Pool Activity👤 Insider Trades
Institutional Holders
7
Total Value
$648.9K
Ownership %
3.1%

🏦 Top Institutional Holders

Hemenway Trust Co LLC
274.0K shares
$449.4K
2.18% ownership
VANGUARD GROUP INC
59.0K shares
$96.7K
0.47% ownership
GEODE CAPITAL MANAGEMENT, LLC
34.9K shares
$57.2K
0.28% ownership
JANE STREET GROUP, LLC
27.2K shares
$44.6K
0.22% ownership
UBS Group AG (UBS)
582 shares
$954

📊 Financials

Income statement, balance sheet, and cash flow from SEC filings.

🏦 Browse Funds

See complete portfolios of top hedge funds.

🎯 AI Signals

Find stocks where multiple funds are accumulating.